Cynata Therapeutics (ASX:CYP): Things are looking up in 2023
Cynata Therapeutics (ASX:CYP) We spoke with Cynata Therapeutics (ASX:CYP) CEO Ross Macdonald about the company’s…
Jade Gas (ASX:JGH) interview with MD Chris Jamieson
Jade Gas (ASX:JGH) We spoke to Jade Gas (ASX:JGH) Managing Director Chris Jamieson about the…
Leo Lithium (ASX:LLL) has a massive lithium project in Mali. Great interview with CEO Simon Hay
Leo Lithium (ASX:LLL) We talked with Leo Lithium (ASX:LLL) CEO Simon Hay about the company’s…
Reward Minerals (ASX:RWD): Interview with CEO Lorry Hughes
Reward Minerals (ASX:RWD) We talked to Reward Minerals CEO Lorry Hughes about the progress his…
High dividend stocks and copper are on the menu today in our Investor Webinar
Looking for high dividend stocks on ASX? Look no further! In this week’s investor webinar…
Remsense (ASX:REM): Interview with CEO Steve Brown
Remsense (ASX:REM) We spoke with Remsense (ASX:REM) CEO Steve Brown about the significant functionality which the…
Stocks Down Under Concierge goes global, a look at NIC and crunch time for the NASDAQ in 2023
Stocks Down Under Concierge goes global! We will start trialling international stocks on Nasdaq, NYSE…
How low can BrainChip go, Rare Earths and Gold… all this in our weekly Investor Webinar!
How low can BrainChip go? In this week’s investor webinar we look at BrainChip‘s (ASX:BRN)…
Neurizer (ASX:NRZ): Interview with CEO Phil Staveley
Neurizer (ASX:NRZ) We spoke to Neurizer (ASX:NRZ) CEO Phil Staveley about the enormous potential value of…
Investor Webinar 5 April 2023: Cyclopharm (ASX:CYC), using a Stop Loss and why we’re looking at Rare Earths now
In this Investor Webinar: – Cyclopharm (ASX:CYC), one of our favourite stocks, should be…
Zinc play Belararox (ASX:BRX) is kicking goals in Argentina!
Belararox (ASX:BRX) is making headway in Argentina We spoke with Belararox CEO, Arvind Misra, about the…
Cyclopharm (ASX:CYC) is expecting FDA approval for Technegas by September 2023!
Cyclopharm (ASX:CYC) is nearly there with its US ambitions for Technegas! We spoke with Cyclopharm CEO…
The extraordinary case of Weebit Nano: Marc Kennis talks ReRAM on Ausbiz
Weebit Nano’s ReRAM Our own Marc Kennis appeared on AusBiz and provided a comprehensive analysis and…
Vectus Biosystems (ASX: VBS): Interview with CEO Dr Karen Duggan
Vectus Biosystems (ASX:VBS) We spoke with Dr Karen Duggan, CEO of drug developer Vectus Biosystems (ASX:VBS),…
Update on Weebit Nano and 4 stocks to watch: Investor Webinar 1 March 2023
In this Investor Webinar: – An update on the performance of our stock picking service Concierge….
Immuron (ASX:IMC): Interview with CEO Steve Lydeamore
Immuron (ASX:IMC) We spoke with Immuron CEO Steve Lydeamore about the ongoing clinical work with the…
Sarytogan Graphite (ASX:SGA): Interview with CEO Sean Gregory
Sarytogan Graphite We talked with Sarytogan Graphite (ASX:SGA) CEO Sean Gregory about this company’s massive and…